Research ArticleOpen AccessGoogle Scholar indexed
Omega-3 Fatty Acids and Risk of Atrial Fibrillation: A Case Report and Literature Review
Pharmacy Department, Clinical Pharmacy Unit, Ahmadi Hospital, Ahmadi, Kuwait
Internal Medicine Department, Ahmadi Hospital, Ahmadi, Kuwait
Critical Care Unit, Ahmadi Hospital, Ahmadi, Kuwait
Pharmacy Department, Clinical Pharmacy Unit, Ahmadi Hospital, Ahmadi, Kuwait
Kuwait Oil Company, Ahmadi, Kuwait
- 1 Pharmacy Department, Clinical Pharmacy Unit, Ahmadi Hospital, Ahmadi, Kuwait
- 2 Internal Medicine Department, Ahmadi Hospital, Ahmadi, Kuwait
- 3 Critical Care Unit, Ahmadi Hospital, Ahmadi, Kuwait
- 4 Pharmacy Department, Clinical Pharmacy Unit, Ahmadi Hospital, Ahmadi, Kuwait
- 5 Kuwait Oil Company, Ahmadi, Kuwait
Open Journal of Internal Medicine·Volume 12 (2022)·Pages 52–55·Published 25 January 2022·DOI10.4236/ojim.2022.121007
Copy link · social · email
Abstract
Omega-3 fatty acids are one of the most used food supplements. However, atrial fibrillation has been recently presented as a rare adverse drug event following ingestion of high doses of this food supplement.
KeywordsAtrial FibrillationOmega-3Food Supplements
- Jin, M.J. and Kim, J.K. (2021) Customer Adoption Factors for In-Flight Entertainment and Connectivity. Research in Transportation Business & Management, Article ID: 100759. (In Press) https://doi.org/10.1016/j.rtbm.2021.100759
- Albert, C.M., Cook, N.R., Pester, J., et al. (2021) Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial. JAMA, 325, 1061-1073. https://doi.org/10.1001/jama.2021.1489
- García-Cortés, M., Lucena, M.I., Pachkoria, K., Borraz, Y., Hidalgo, R., Andrade, R.J. and Spanish Group for the Study of Drug-Induced Liver Disease (2008) Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Geham. Alimentary Pharmacology and Therapeutics, 27, 780-789. https://doi.org/10.1111/j.1365-2036.2008.03655.x
- Kris-Etherton, P.M., Harris, W.S. and Appel, L.J. (2002) Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease. Circulation, 106, 2747-2757. https://doi.org/10.1161/01.CIR.0000038493.65177.94
- Skulas-Ray, A.C., Wilson, P.W., Harris, W.S., Brinton, E.A., Kris-Etherton, P.M., Richter, C.K., Jacobson, T.A., Engler, M.B., Miller, M., Robinson, J.G. and Blum, C.B. (2019) Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory from the American Heart Association. Circulation, 140, e673-e691. https://doi.org/10.1161/CIR.0000000000000709
- Nicholls, S.J., Lincoff, A.M., Garcia, M., Bash, D., Ballantyne, C.M., Barter, P.J., Davidson, M.H., Kastelein, J.J., Koenig, W., McGuire, D.K. and Mozaffarian, D. (2020) Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. JAMA, 324, 2268-2280. https://doi.org/10.1001/jama.2020.22258
- Bhatt, D.L., Steg, P.G., Miller, M., Brinton, E.A., Jacobson, T.A., Ketchum, S.B., Doyle Jr., R.T., Juliano, R.A., Jiao, L., Granowitz, C. and Tardif, J.C. (2019) Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. New England Journal of Medicine, 380, 11-22. https://doi.org/10.1056/NEJMoa1812792
- Kalstad, A.A., Myhre, P.L., Laake, K., Tveit, S.H., Schmidt, E.B., Smith, P., Nilsen, D.W.T., Tveit, A., Fagerland, M.W., Solheim, S. and Seljeflot, I. (2021) Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized, Controlled Trial. Circulation, 143, 528-539. https://doi.org/10.1161/CIRCULATIONAHA.120.052209